Puma Biotechnology Inc (PBYI)

SG&A Expense Growth

-11.17%

Fiscal year · Period ending:

PBYI logo

PBYI SG&A Expense Growth

Latest reported-11.17%
PBYI FY SG&A Growth (YoY) (0.00% → -11.17%)
High-resolution chart · PNG

PBYI sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Puma Biotechnology Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
-11.1697%
-10.2398%
-0.7446%
-22.6289%
-1.8517%
-16.3451%
-3.1197%
37.0197%
98.3271%
69.1824%
63.9175%
98.2221%
-60.5363%
166.1062%
58,234.9211%
-5.1081%
19.5484%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.